AbbVie ( (ABBV) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AbbVie’s stock has experienced a downturn due to concerns over its high price-to-earnings ratio and negative equity, despite the company’s strategic moves to delay generic competition for its drug RINVOQ until 2037 and its strong earnings. While the company has raised its guidance and is investing in research and development, these positive aspects are overshadowed by valuation worries and financial leverage risks.
More about AbbVie
YTD Price Performance: 22.38%
Average Trading Volume: 5,477,944
Technical Sentiment Signal: Buy
Current Market Cap: $373.9B
For further insights into ABBV stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.